doi: 10.1038/d41586-021-01222-5.
Pfizer COVID vaccine protects against worrying coronavirus variants
- PMID:33963317
- DOI: 10.1038/d41586-021-01222-5
Item in Clipboard
Pfizer COVID vaccine protects against worrying coronavirus variants
Ewen Callaway. Nature.2021 May.
Display options
Format
Display options
Format
No abstract available
Keywords: SARS-CoV-2; Vaccines.
Similar articles
- Coronavirus variants are spreading in India - what scientists know so far.Vaidyanathan G.Vaidyanathan G.Nature. 2021 May;593(7859):321-322. doi: 10.1038/d41586-021-01274-7.Nature. 2021.PMID:33976409No abstract available.
- Neutralizing SARS-CoV-2.Poeschla E.Poeschla E.Elife. 2020 Dec 15;9:e64496. doi: 10.7554/eLife.64496.Elife. 2020.PMID:33320086Free PMC article.
- Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.Zhou X, Wang H, Ji Q, Du M, Liang Y, Li H, Li F, Shang H, Zhu X, Wang W, Jiang L, Stepanov AV, Ma T, Gong N, Jia X, Gabibov AG, Lou Z, Lu Y, Guo Y, Zhang H, Yang X.Zhou X, et al.Protein Cell. 2021 Oct;12(10):818-823. doi: 10.1007/s13238-021-00840-z. Epub 2021 Apr 28.Protein Cell. 2021.PMID:33909239Free PMC article.No abstract available.
- COVID-19: Significance of antibodies.Assadiasl S, Fatahi Y, Zavvar M, Nicknam MH.Assadiasl S, et al.Hum Antibodies. 2020;28(4):287-297. doi: 10.3233/HAB-200429.Hum Antibodies. 2020.PMID:32986664Review.
- A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain.Niu L, Wittrock KN, Clabaugh GC, Srivastava V, Cho MW.Niu L, et al.Front Immunol. 2021 Apr 28;12:647934. doi: 10.3389/fimmu.2021.647934. eCollection 2021.Front Immunol. 2021.PMID:33995366Free PMC article.Review.
Cited by
- Design and finite element modeling of two-dimensional nanomechanical biosensors for SARS-CoV-2 detection.Payandehpeyman J, Parvini N, Moradi K, Hashemian N.Payandehpeyman J, et al.Diam Relat Mater. 2022 Oct;128:109263. doi: 10.1016/j.diamond.2022.109263. Epub 2022 Jul 22.Diam Relat Mater. 2022.PMID:35891677Free PMC article.
- SARS-CoV-2 Vaccines: Where Are We Now?Flanagan KL, MacIntyre CR, McIntyre PB, Nelson MR.Flanagan KL, et al.J Allergy Clin Immunol Pract. 2021 Oct;9(10):3535-3543. doi: 10.1016/j.jaip.2021.07.016. Epub 2021 Aug 13.J Allergy Clin Immunol Pract. 2021.PMID:34400116Free PMC article.
- A Review of Different Vaccines and Strategies to Combat COVID-19.Sabitha S, Shobana N, Prakash P, Padmanaban S, Sathiyashree M, Saigeetha S, Chakravarthi S, Uthaman S, Park IK, Samrot AV.Sabitha S, et al.Vaccines (Basel). 2022 May 9;10(5):737. doi: 10.3390/vaccines10050737.Vaccines (Basel). 2022.PMID:35632493Free PMC article.Review.
- A global picture: therapeutic perspectives for COVID-19.Chavda VP, Kapadia C, Soni S, Prajapati R, Chauhan SC, Yallapu MM, Apostolopoulos V.Chavda VP, et al.Immunotherapy. 2022 Apr;14(5):351-371. doi: 10.2217/imt-2021-0168. Epub 2022 Feb 21.Immunotherapy. 2022.PMID:35187954Free PMC article.Review.
- Research progress on vaccine efficacy against SARS-CoV-2 variants of concern.Bian L, Liu J, Gao F, Gao Q, He Q, Mao Q, Wu X, Xu M, Liang Z.Bian L, et al.Hum Vaccin Immunother. 2022 Nov 30;18(5):2057161. doi: 10.1080/21645515.2022.2057161. Epub 2022 Apr 19.Hum Vaccin Immunother. 2022.PMID:35438600Free PMC article.Review.
References
- Abu-Raddad, L. J. & Butt, A. A. N. Engl. J. Med.https://doi.org/10.1056/NEJMc2104974 (2021). - PubMed - DOI
- Shinde, V. et al. N. Engl. J. Med.https://doi.org/10.1056/NEJMoa2103055 (2021). - PubMed - DOI - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous